Board of Directors

The Board of Directors of the U.Va. Licensing & Ventures Group is composed of men and women from a variety of industries, academia and the medical profession. Among this diverse group are experienced entrepreneurs, retired senior executives, medical professionals, U.Va. faculty and venture capital experts. Meeting quarterly, the board assists the Licensing & Ventures Group in long-range and strategic planning endeavors.

Peter Barris

President's Appointee

Managing General Partner

New Enterprise Associates

Erik L. Hewlett, M.D.

Erik L. Hewlett, M.D.

Chair

Board Chair
Professor of Medicine and of Microbiology, Immunology and Cancer Biology

University of Virginia

John S. Lazo

Associate Dean for Basic Research
Professor of Pharmacology & Chemistry

University of Virginia

Helga L. Leftwich

Helga L. Leftwich

Partner

Hutchison PLLC

Michael J. Lenox, Ph.D.

President's Appointee

Academic Director and Associate Dean of the Batten Institute
Darden School of Business

University of Virginia

John MacFarlane III

Board of Visitors Representative

Managing Partner

Arrochar Management LLC

Ron Newbold

Vice President, External R&D Innovation

Pfizer

Phillip A. Parrish

Interim Vice President for Research
Principal Scientist in the Department of Materials Science & Engineering

Univesity of Virginia

Brian A. Pollok

Brian A. Pollok

Founder, President and CEO, Propagenix Inc. and Founder, Neoantigenics

Richard P. Shannon, M.D.

Executive Vice President for Health Affairs
Louise Nerancy Professor of Health Policy Science

University of Virginia

Charles F. Stamm

Charles F. Stamm

Former Principal

Deloitte & Touche LLP